Abby Fuller, PhD

Dr. Fuller has more than 23 years drug discovery and development experience across neuroscience, immunology and inflammation indications. Her 17 years clinical research experience across Phase I-III studies includes 14 years at Fortrea (formerly Labcorp and Covance), where she has supported development and implementation of Phase I and II clinical trials in patients with neurodegenerative diseases including Alzheimer’s disease. Dr. Fuller earned her Doctorate of Pharmacology from Northwestern Feinberg School of Medicine with a focus on Alzheimer’s drug discovery and development.​